If you are taking a GLP-1 and worried about side effects, under-eating, or what to eat from day to day, book a free 30-minute discovery call for personalised support with nutrition, meal structure, and sustainable habits
Lancet Diabetes & Endocrinology, 6 (4), 275286
If someone has diabetes, it means their body doesnt properly produce or respond to insulin
Section 7: Managing UTI Risk in Patients on Semaglutide Section 7: Managing UTI Risk in Patients on Semaglutide In the context of increasing semaglutide use for Type 2 diabetes and obesity management, understanding how to mitigate the associated risk of urinary tract infections (UTIs) is essential for healthcare providers and patients alike
Le mdicament contre l'obsit Wegovy lanc en France, sans remboursement Publi le Mis jour le Le Wegovy, mdicament vedette de Novo Nordisk contre l'obsit, a obtenu l'autorisation d'tre commercialis en France, a annonc mardi le groupe pharmaceutique danois